0001209191-22-007514.txt : 20220207
0001209191-22-007514.hdr.sgml : 20220207
20220207172042
ACCESSION NUMBER: 0001209191-22-007514
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220204
FILED AS OF DATE: 20220207
DATE AS OF CHANGE: 20220207
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shameze Rampertab
CENTRAL INDEX KEY: 0001721810
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19437
FILM NUMBER: 22598514
MAIL ADDRESS:
STREET 1: C/O ZOMEDICA PHARMACEUTICALS CORP.
STREET 2: 3928 VARSITY DRIVE
CITY: ANN ARBOR
STATE: MI
ZIP: 48108
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ASENSUS SURGICAL, INC.
CENTRAL INDEX KEY: 0000876378
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 112962080
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 TW ALEXANDER DRIVE
STREET 2: SUITE 160
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: 919-765-8400
MAIL ADDRESS:
STREET 1: 1 TW ALEXANDER DRIVE
STREET 2: SUITE 160
CITY: DURHAM
STATE: NC
ZIP: 27703
FORMER COMPANY:
FORMER CONFORMED NAME: TRANSENTERIX, INC.
DATE OF NAME CHANGE: 20190712
FORMER COMPANY:
FORMER CONFORMED NAME: TRANSENTERIX INC.
DATE OF NAME CHANGE: 20131210
FORMER COMPANY:
FORMER CONFORMED NAME: SafeStitch Medical, Inc.
DATE OF NAME CHANGE: 20080211
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-02-04
0
0000876378
ASENSUS SURGICAL, INC.
ASXC
0001721810
Shameze Rampertab
C/O ASENSUS SURGICAL, INC.
1 TW ALEXANDER DRIVE, SUITE 160
DURHAM
NC
27703
0
1
0
0
EVP, Chief Financial Officer
Common Stock
2022-02-04
4
M
0
98608
0.00
A
110717
D
Common Stock
2022-02-04
4
F
0
26711
0.80
D
84006
D
Stock Options
0.80
2022-02-04
4
A
0
222500
0.00
A
2029-02-04
Common Stock
222500
222500
D
Restricted Stock Units
0.00
2022-02-04
4
A
0
187250
0.00
A
Common Stock
187250
187250
D
Restricted Stock Units
0.00
2022-02-04
4
A
0
187250
0.00
A
Common Stock
187250
187250
D
Restricted Stock Units
0.00
2022-02-04
4
A
0
84270
0.00
A
Common Stock
84270
84270
D
Restricted Stock Units
0.00
2022-02-04
4
M
0
19704
0.00
D
Common Stock
19704
39408
D
Restricted Stock Units
0.00
2022-02-04
4
M
0
19704
0.00
D
Common Stock
19704
39408
D
Restricted Stock Units
0.00
2022-02-04
4
M
0
59200
0.00
D
Common Stock
59200
0
D
This transaction represents the payment of a tax liability on the lapse of forfeiture restrictions on a derivative security and acquisition of the underlying shares.
Vests one-third annually on each of February 4, 2023, 2024 and 2025, subject to acceleration as set forth in the Registrant's Amended and Restated Incentive Compensation Plan ("Plan") and the Reporting Person's Employment Agreement with the Registrant ("Employment Agreement").
Each restricted stock unit ("RSU") represents the right to receive one share of the Registrant's common stock.
Forfeiture restrictions will lapse on the RSUs in three equal installments on each of February 4, 2023, 2024 and 2025, as long as the Reporting Person remains in continuous service during the vesting period, subject to acceleration as set forth in the Plan and the Employment Agreement.
Each performance-based restricted stock unit ("PRSU") represents the right to receive one share of the Registrant's common stock.
PRSU award with time-based vesting in three equal installments on each of February 4, 2023, 2024 and 2025, and performance-based vesting only if designated corporate goals are met.
Represents a discretionary retention bonus. Forfeiture restrictions will lapse on the RSUs on February 4, 2023, as long as the Reporting Person remains in continuous service during the vesting period.
Lapse of forfeiture on one-third of an award of RSUs from this grant made on February 8, 2021. Forfeiture restrictions will lapse on the remaining RSUs in two equal installments on February 4, 2023 and 2024, as long as the Reporting Person remains in continuous service during the vesting period, subject to acceleration as set forth in the Registrant's Plan and the Reporting Person's Employment Agreement.
Lapse of forfeiture restrictions on one-third of a PRSU award granted on February 8, 2021, upon the achievement of time and performance goals. Forfeiture restrictions will lapse on the remaining PRSUs in two equal installments on each of February 4, 2023 and 2024, as long as the Reporting Person provides continuous service during the vesting period, subject to acceleration as set forth in the Registrant's Plan and the Reporting Person's Employment Agreement.
Lapse of forfeiture restrictions on a discretionary retention award made on February 8, 2021.
/s/ Joshua Weingard, as attorney-in-fact for Shameze Rampertab
2022-02-07